Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 51

Results For "Asia"

686 News Found

Mylab appoints Rajesh Patel as the Executive Director of In-Vitro Diagnostics Business
People | May 09, 2022

Mylab appoints Rajesh Patel as the Executive Director of In-Vitro Diagnostics Business

He was previously working as the CEO of IVD business at Trivitron Healthcare and drove its growth through innovation


Thalassemia children require comprehensive treatment approach: Dr Sunil Bhat, Narayana Health City
Public Health | May 08, 2022

Thalassemia children require comprehensive treatment approach: Dr Sunil Bhat, Narayana Health City

There is a need for the Ministry of Health to put it on the priority list and address the issues, which are numerous


Quality issues force Novartis to suspend production of radioligand therapy medicines
News | May 08, 2022

Quality issues force Novartis to suspend production of radioligand therapy medicines

The production suspension impacts commercial and clinical trial supply


Avantor to create a new manufacturing hub in Singapore
News | May 05, 2022

Avantor to create a new manufacturing hub in Singapore

The new hub, which brings Avantor solutions closer to regional customers and strengthens global supply chain capabilities, will be fully operational early next year


Merck invests $110 million to expand production site in China
News | May 05, 2022

Merck invests $110 million to expand production site in China

Company will expand the existing production site in Wuxi to significantly increase biopharma single-use assemblies and custom design capabilities


14.9 million excess deaths associated with the Covid-19 pandemic in 2020 and 2021
News | May 05, 2022

14.9 million excess deaths associated with the Covid-19 pandemic in 2020 and 2021

The report has estimated 4.74 million deaths for India in 2020 and 2021,


Pfizer sets up global drug development centre in Chennai
News | May 04, 2022

Pfizer sets up global drug development centre in Chennai

The facility is among 12 centres established worldwide, and the first in Asia


Juniper Biologics signs exclusive license agreement with Helsinn for infigratinib (INN) for the emerging markets including India
Biotech | May 04, 2022

Juniper Biologics signs exclusive license agreement with Helsinn for infigratinib (INN) for the emerging markets including India

Infigratinib is not FDA-, Health Canada- or Therapeutics Goods Association-approved for any other indication


Intravacc signs an exclusive license agreement with Zhifei Lvzhu Biopharmaceutical
Biotech | May 02, 2022

Intravacc signs an exclusive license agreement with Zhifei Lvzhu Biopharmaceutical

Avacc 3 has significant advantages over existing whooping cough vaccines


StanPlus appoints Gurjit Singh as COO and Founding Member
People | May 02, 2022

StanPlus appoints Gurjit Singh as COO and Founding Member

He will be leading the business, operations, P&L, and growth strategy for StanPlus